History of Leuka
In Our History
In 2016 Leuka is a founding partner in a major new UK platform for stem cell transplantation called IMPACT.
2016 Leuka invests £1m in a major new UK platform for stem cell transplantation clinical trials. The project, called IMPACT, is aimed to accelerate the delivery of prospective clinical trials to improve outcomes for eligible patients.
2015 Leuka launches a new fellowship initiative – John Goldman Fellowships for Future Science awards.
2014 Leuka restructures as a charitable incorporated organisation or CIO. The CIO is registered with the Charity Commission with the same name, Leuka, and with registered number 1154856.
2014 Chris Corbin OBE is appointed as Chairman of Trustees following the untimely death of Professor John Goldman, Leuka’s founding Chairman for 31 years. You can read our tribute to Professor Goldman in full here.
2012 Leuka celebrates its 30th anniversary and embarks on fund raising for a major initiative to raise over £1m each year for research.
2011 Trustees appoint a Chief Executive Officer for the first time to develop the charity’s ambitious five-year strategy.
2005 A new facility opens for processing blood and bone marrow stem cells destined for transplantation.
2004 A dedicated Clinical Trials Unit is opened to study new drugs and to design pioneering and effective therapies for leukaemia patients worldwide.
2002 The three-storey Catherine Lewis Centre opens its doors to patients and staff on Tuesday 25 June 2002. The NHS, in collaboration with Imperial College London, now manages this Centre.
1998 A £10 million capital appeal is launched to fund the building of a new specialist leukaemia centre at Hammersmith Hospital.
1986 It funds a major redevelopment of the Hammersmith’s Dacie Ward, dedicated to the treatment of leukaemia patients.
1982 Leuka is founded by Lester Cazin, a leukaemia patient at Hammersmith Hospital, to raise funds to support research.